Meta Platforms, Inc. (ZMET)
Cboe Canada · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 8.370 |
|---|---|
| 52-week range | 7.150 – 10.330 |
| Return, 1 month / 3 months | −18.7% / +4.3% |
| Return, 1 year / 3 years | −18.8% / – |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 42.7% |
| Worst drawdown (1 year) | -30.7% |
| Average daily value traded | 0.00M CAD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Meta Platforms builds and runs social media and messaging services used by people and businesses around the world. Its main products include Facebook, Instagram, WhatsApp and Messenger, along with advertising tools that let businesses place paid promotions across those services. The company also develops virtual and augmented reality hardware and software. Meta Platforms is based in Menlo Park, California, in the United States, and its customers range from individual users to advertisers of many sizes.
On this site Meta Platforms, Inc. appears as a stock on the Cboe Canada (Canada), code ZMET, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Meta Platforms, Inc. (ZMET) trades on the Cboe Canada in Canada. It last closed at CAD 8.370 on 27 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 112 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.8% and over the last three months it rose 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Cboe Canada
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.2% | ||
| From 52-week high | -19.0% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.3% | ||
| 6-month return | -9.0% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.7% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CAD | ||
| Zero-volume days | 16.7% | ||
| Income | 7 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −11.0% |
|---|---|
| 1 month | −18.7% |
| 3 months | +4.3% |
| 6 months | −9.0% |
| 1 year | −18.8% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.831 / 8.559 |
|---|---|
| Golden / death cross (60 days) | Golden, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.267 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2026 | USD 0.0071 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Cboe Canada; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.